KeyBanc Cuts Oddity Tech (ODD) PT to $80 Due to Mixed Healthcare IT Setup

Oddity Tech Ltd. (NASDAQ:ODD) is one of the best performing new tech stocks to invest in. On October 8, KeyBanc lowered the firm’s price target on Oddity to $80 from $90, while keeping an Overweight rating on the shares. This sentiment came ahead of the company’s Q3 2025 earnings report, as KeyBanc believes that the setup is mixed across the Healthcare Information Technology landscape.

Earlier in Q2, Oddity Tech generated a net revenue of $241 million, which marked a 25% year-over-year increase from $193 million in Q2 2024. Gross profit also rose by 25% to $174 million, which resulted in a gross margin of 72.3%, up by 0.01%. Net income for the quarter was $49 million, and adjusted net income was $57 million, which was a 12% rise.

KeyBanc Cuts Oddity Tech (ODD) PT to $80 Due to Mixed Healthcare IT Setup

Due to the momentum and high-visibility backlog of repeat orders, Oddity raised its financial outlook for the full year ending December 31, 2025. Net revenue is now projected to be between $799-$804 million, which implies a 23% to 24% annual growth. This is higher than the prior forecast of $790 to $798 million. Oddity’s growth is driven by double-digit online revenue growth in both Il Makiage and SpoiledChild, as well as the accelerating international expansion.

Oddity Tech Ltd. (NASDAQ:ODD) is a consumer tech company that builds digital-first brands for the beauty and wellness industries in the US and internationally.

While we acknowledge the potential of ODD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ODD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.